Treatment of Focal Hyperhidrosis
Background: Focal hyperhidrosis is not rare, affecting over 2.5% of the population. This condition is often socially and professionally debilitating, leading to significant quality of life impairment. It most commonly involves the axillae, palms, soles, and face. Objective: To review hyperhidrosis a...
Gespeichert in:
| Veröffentlicht in: | Journal of Cutaneous Medicine and Surgery 2007-03, Vol.11 (2), p.67-77 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 77 |
|---|---|
| container_issue | 2 |
| container_start_page | 67 |
| container_title | Journal of Cutaneous Medicine and Surgery |
| container_volume | 11 |
| creator | Murray, Christian A. Cohen, Joel L. Solish, Nowell |
| description | Background:
Focal hyperhidrosis is not rare, affecting over 2.5% of the population. This condition is often socially and professionally debilitating, leading to significant quality of life impairment. It most commonly involves the axillae, palms, soles, and face.
Objective:
To review hyperhidrosis and discuss and compare the treatment options currently available.
Conclusions:
Topical or systemic therapies may be helpful for patients with mild disease. Invasive surgical options, although often effective, are limited by complications. More recently, botulinum toxin injection has proven to be a safe and successful treatment for hyperhidrosis and results in high patient satisfaction. Botulinum toxin A (Botox, Allergan Inc., Irvine, CA) is currently approved in the United States, Canada, the United Kingdom, and many other countries for the treatment of axillary hyperhidrosis and is routinely used off-label for other anatomic sites. |
| doi_str_mv | 10.2310/7750.2007.00012 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_229811566</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.2310_7750.2007.00012</sage_id><sourcerecordid>1244864551</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-3d101f3c07719aed00345aadd04c066c97faf158bf11187819d1332bc4da539d3</originalsourceid><addsrcrecordid>eNp1kD1PwzAQhi0EoqUws6EIiY20d7EdOyOqKEWqxFJmy_UHpGqbYqdD_z0OjdSJ6W547u69h5B7hHFBESZC8NQBiDEAYHFBhlgizwVCdZn6AmjOBGcDchPjukOQs2syQEEFoyiGJFsGp9ut27VZ47NZY_Qmmx_3LnzXNjSxjrfkyutNdHd9HZHP2etyOs8XH2_v05dFbhjyNqcWAT01IARW2lkAyrjW1gIzUJamEl575HLlEVEKiZVFSouVYVZzWlk6Io-nvfvQ_BxcbNW6OYRdOqmKopIpeFkmaHKCTMoWg_NqH-qtDkeFoDohqhOiOiHqT0iaeOjXHlZbZ898byABTz2gY3reB70zdTxzUkrKJSTu-cRF_eXO2f67-wu28nHT</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>229811566</pqid></control><display><type>article</type><title>Treatment of Focal Hyperhidrosis</title><source>MEDLINE</source><source>SAGE Complete</source><creator>Murray, Christian A. ; Cohen, Joel L. ; Solish, Nowell</creator><creatorcontrib>Murray, Christian A. ; Cohen, Joel L. ; Solish, Nowell</creatorcontrib><description>Background:
Focal hyperhidrosis is not rare, affecting over 2.5% of the population. This condition is often socially and professionally debilitating, leading to significant quality of life impairment. It most commonly involves the axillae, palms, soles, and face.
Objective:
To review hyperhidrosis and discuss and compare the treatment options currently available.
Conclusions:
Topical or systemic therapies may be helpful for patients with mild disease. Invasive surgical options, although often effective, are limited by complications. More recently, botulinum toxin injection has proven to be a safe and successful treatment for hyperhidrosis and results in high patient satisfaction. Botulinum toxin A (Botox, Allergan Inc., Irvine, CA) is currently approved in the United States, Canada, the United Kingdom, and many other countries for the treatment of axillary hyperhidrosis and is routinely used off-label for other anatomic sites.</description><identifier>ISSN: 1203-4754</identifier><identifier>EISSN: 1615-7109</identifier><identifier>DOI: 10.2310/7750.2007.00012</identifier><identifier>PMID: 17374317</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Axilla ; Biological and medical sciences ; Botulinum Toxins, Type A - administration & dosage ; Botulinum Toxins, Type A - therapeutic use ; Cholinergic Antagonists - therapeutic use ; Dermatology ; Hand ; Humans ; Hyperhidrosis - diagnosis ; Hyperhidrosis - drug therapy ; Hyperhidrosis - physiopathology ; Hyperhidrosis - therapy ; Injections, Intradermal ; Iontophoresis ; Lipectomy ; Medical sciences ; Neuromuscular Agents - administration & dosage ; Neuromuscular Agents - therapeutic use ; Skin involvement in other diseases. Miscellaneous. General aspects ; Sympathectomy</subject><ispartof>Journal of Cutaneous Medicine and Surgery, 2007-03, Vol.11 (2), p.67-77</ispartof><rights>2007 Canadian Dermatology Association</rights><rights>2007 INIST-CNRS</rights><rights>Copyright Springer Science & Business Media Mar-Apr 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-3d101f3c07719aed00345aadd04c066c97faf158bf11187819d1332bc4da539d3</citedby><cites>FETCH-LOGICAL-c415t-3d101f3c07719aed00345aadd04c066c97faf158bf11187819d1332bc4da539d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.2310/7750.2007.00012$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.2310/7750.2007.00012$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>313,314,776,780,788,21798,27899,27901,27902,43597,43598</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18883580$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17374317$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Murray, Christian A.</creatorcontrib><creatorcontrib>Cohen, Joel L.</creatorcontrib><creatorcontrib>Solish, Nowell</creatorcontrib><title>Treatment of Focal Hyperhidrosis</title><title>Journal of Cutaneous Medicine and Surgery</title><addtitle>J Cutan Med Surg</addtitle><description>Background:
Focal hyperhidrosis is not rare, affecting over 2.5% of the population. This condition is often socially and professionally debilitating, leading to significant quality of life impairment. It most commonly involves the axillae, palms, soles, and face.
Objective:
To review hyperhidrosis and discuss and compare the treatment options currently available.
Conclusions:
Topical or systemic therapies may be helpful for patients with mild disease. Invasive surgical options, although often effective, are limited by complications. More recently, botulinum toxin injection has proven to be a safe and successful treatment for hyperhidrosis and results in high patient satisfaction. Botulinum toxin A (Botox, Allergan Inc., Irvine, CA) is currently approved in the United States, Canada, the United Kingdom, and many other countries for the treatment of axillary hyperhidrosis and is routinely used off-label for other anatomic sites.</description><subject>Axilla</subject><subject>Biological and medical sciences</subject><subject>Botulinum Toxins, Type A - administration & dosage</subject><subject>Botulinum Toxins, Type A - therapeutic use</subject><subject>Cholinergic Antagonists - therapeutic use</subject><subject>Dermatology</subject><subject>Hand</subject><subject>Humans</subject><subject>Hyperhidrosis - diagnosis</subject><subject>Hyperhidrosis - drug therapy</subject><subject>Hyperhidrosis - physiopathology</subject><subject>Hyperhidrosis - therapy</subject><subject>Injections, Intradermal</subject><subject>Iontophoresis</subject><subject>Lipectomy</subject><subject>Medical sciences</subject><subject>Neuromuscular Agents - administration & dosage</subject><subject>Neuromuscular Agents - therapeutic use</subject><subject>Skin involvement in other diseases. Miscellaneous. General aspects</subject><subject>Sympathectomy</subject><issn>1203-4754</issn><issn>1615-7109</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kD1PwzAQhi0EoqUws6EIiY20d7EdOyOqKEWqxFJmy_UHpGqbYqdD_z0OjdSJ6W547u69h5B7hHFBESZC8NQBiDEAYHFBhlgizwVCdZn6AmjOBGcDchPjukOQs2syQEEFoyiGJFsGp9ut27VZ47NZY_Qmmx_3LnzXNjSxjrfkyutNdHd9HZHP2etyOs8XH2_v05dFbhjyNqcWAT01IARW2lkAyrjW1gIzUJamEl575HLlEVEKiZVFSouVYVZzWlk6Io-nvfvQ_BxcbNW6OYRdOqmKopIpeFkmaHKCTMoWg_NqH-qtDkeFoDohqhOiOiHqT0iaeOjXHlZbZ898byABTz2gY3reB70zdTxzUkrKJSTu-cRF_eXO2f67-wu28nHT</recordid><startdate>20070301</startdate><enddate>20070301</enddate><creator>Murray, Christian A.</creator><creator>Cohen, Joel L.</creator><creator>Solish, Nowell</creator><general>SAGE Publications</general><general>Decker</general><general>SAGE PUBLICATIONS, INC</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope></search><sort><creationdate>20070301</creationdate><title>Treatment of Focal Hyperhidrosis</title><author>Murray, Christian A. ; Cohen, Joel L. ; Solish, Nowell</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-3d101f3c07719aed00345aadd04c066c97faf158bf11187819d1332bc4da539d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Axilla</topic><topic>Biological and medical sciences</topic><topic>Botulinum Toxins, Type A - administration & dosage</topic><topic>Botulinum Toxins, Type A - therapeutic use</topic><topic>Cholinergic Antagonists - therapeutic use</topic><topic>Dermatology</topic><topic>Hand</topic><topic>Humans</topic><topic>Hyperhidrosis - diagnosis</topic><topic>Hyperhidrosis - drug therapy</topic><topic>Hyperhidrosis - physiopathology</topic><topic>Hyperhidrosis - therapy</topic><topic>Injections, Intradermal</topic><topic>Iontophoresis</topic><topic>Lipectomy</topic><topic>Medical sciences</topic><topic>Neuromuscular Agents - administration & dosage</topic><topic>Neuromuscular Agents - therapeutic use</topic><topic>Skin involvement in other diseases. Miscellaneous. General aspects</topic><topic>Sympathectomy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Murray, Christian A.</creatorcontrib><creatorcontrib>Cohen, Joel L.</creatorcontrib><creatorcontrib>Solish, Nowell</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><jtitle>Journal of Cutaneous Medicine and Surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Murray, Christian A.</au><au>Cohen, Joel L.</au><au>Solish, Nowell</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of Focal Hyperhidrosis</atitle><jtitle>Journal of Cutaneous Medicine and Surgery</jtitle><addtitle>J Cutan Med Surg</addtitle><date>2007-03-01</date><risdate>2007</risdate><volume>11</volume><issue>2</issue><spage>67</spage><epage>77</epage><pages>67-77</pages><issn>1203-4754</issn><eissn>1615-7109</eissn><abstract>Background:
Focal hyperhidrosis is not rare, affecting over 2.5% of the population. This condition is often socially and professionally debilitating, leading to significant quality of life impairment. It most commonly involves the axillae, palms, soles, and face.
Objective:
To review hyperhidrosis and discuss and compare the treatment options currently available.
Conclusions:
Topical or systemic therapies may be helpful for patients with mild disease. Invasive surgical options, although often effective, are limited by complications. More recently, botulinum toxin injection has proven to be a safe and successful treatment for hyperhidrosis and results in high patient satisfaction. Botulinum toxin A (Botox, Allergan Inc., Irvine, CA) is currently approved in the United States, Canada, the United Kingdom, and many other countries for the treatment of axillary hyperhidrosis and is routinely used off-label for other anatomic sites.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>17374317</pmid><doi>10.2310/7750.2007.00012</doi><tpages>11</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1203-4754 |
| ispartof | Journal of Cutaneous Medicine and Surgery, 2007-03, Vol.11 (2), p.67-77 |
| issn | 1203-4754 1615-7109 |
| language | eng |
| recordid | cdi_proquest_journals_229811566 |
| source | MEDLINE; SAGE Complete |
| subjects | Axilla Biological and medical sciences Botulinum Toxins, Type A - administration & dosage Botulinum Toxins, Type A - therapeutic use Cholinergic Antagonists - therapeutic use Dermatology Hand Humans Hyperhidrosis - diagnosis Hyperhidrosis - drug therapy Hyperhidrosis - physiopathology Hyperhidrosis - therapy Injections, Intradermal Iontophoresis Lipectomy Medical sciences Neuromuscular Agents - administration & dosage Neuromuscular Agents - therapeutic use Skin involvement in other diseases. Miscellaneous. General aspects Sympathectomy |
| title | Treatment of Focal Hyperhidrosis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T20%3A02%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20Focal%20Hyperhidrosis&rft.jtitle=Journal%20of%20Cutaneous%20Medicine%20and%20Surgery&rft.au=Murray,%20Christian%20A.&rft.date=2007-03-01&rft.volume=11&rft.issue=2&rft.spage=67&rft.epage=77&rft.pages=67-77&rft.issn=1203-4754&rft.eissn=1615-7109&rft_id=info:doi/10.2310/7750.2007.00012&rft_dat=%3Cproquest_cross%3E1244864551%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=229811566&rft_id=info:pmid/17374317&rft_sage_id=10.2310_7750.2007.00012&rfr_iscdi=true |